Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
EUDA Health Holdings ( (EUDA) ) has provided an update.
EUDA Health Holdings has initiated preliminary discussions with Guangdong Cell Biotech to explore a joint venture aimed at advancing biotechnology innovation in Southeast Asia. This collaboration seeks to combine EUDA’s digital healthcare capabilities with Guangdong Cell Biotech’s expertise in stem cell therapies, potentially enhancing EUDA’s market presence and product offerings while fostering innovation in preventive healthcare solutions and regenerative medicine.
More about EUDA Health Holdings
EUDA Health Holdings Limited is a Singapore-based health technology company that operates a unique digital healthcare ecosystem in Southeast Asia, focusing on affordable, accessible healthcare and improved patient outcomes through personalized care. The company’s AI platform aids in medical assessments, triage, and connecting patients with clinicians, supporting various stages of healthcare.
YTD Price Performance: 316.71%
Average Trading Volume: 72,328
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $221.4M
See more data about EUDA stock on TipRanks’ Stock Analysis page.
